NCT00619190View on ClinicalTrials.gov

Study of Aripiprazole to Treat Children and Adolescents With Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Autistic DisorderAsperger SyndromeAutism Spectrum Disorder
Interventions
DRUG

aripiprazole

aripiprazole, open label, flexibly dosed from 1mg to 30mg, provided for up to 12 months

Trial Locations (1)

27514

University of North Carolina, Department of Psychiatry, Chapel Hill

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT00619190 - Study of Aripiprazole to Treat Children and Adolescents With Autism | Biotech Hunter | Biotech Hunter